Sharjah Breaks Global Record in Nutrition Quality Thanks to Innovative Food Techniques
10.4.2025 09:00:00 CEST | Business Wire | Press Release
Sharjah, a leading hub for innovation and excellence in the United Arab Emirates, is making a significant contribution to global food security and sustainability by producing an innovative wheat variety with an unprecedented protein content of 19.3%—the highest recorded worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250404373415/en/
Mleiha Wheat Farm in Sharjah
With growing interest from global food companies, Sharjah is looking into exporting its high-protein wheat to position itself as a key contributor in the international market. Several international certifications, including the HSP food quality certificate and the “Made in Emirates” label have recognized the emirate’s high food standards. The project also won the Best Innovation Award for Sustainability in the UAE, highlighting its impact on environmental protection and agricultural advancement.
Her Excellency Dr. Amna Al Dahak, UAE Minister of Climate Change and Environment, emphasized the project’s role in advancing climate-smart agriculture. She noted that the use of modern technologies, including AI-driven irrigation systems, has been instrumental in the project’s success, reducing water consumption by 30%.
Developed under the directive of His Highness Sheikh Dr. Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, the project cultivated high-protein wheat on 1,428 hectares of desert land using advanced agricultural technologies. This season’s organic wheat harvest is expected to yield around 6,000 tonnes.
The new wheat variety, developed at the Mleiha Wheat Farm, is already being used in local products such as bread, pasta, and cereals, which have attracted both local and international manufacturers.
“Through this project, Sharjah has shown that innovation could overcome even the toughest farming challenges,” Al Dahak added. With an annual output of 15,200 tonnes, the farm now meets Sharjah’s entire wheat demand, significantly reducing reliance on imports.
The farm's success stems from the development of a unique wheat strain, ‘Sharjah 1,’ which is designed to withstand high salinity and drought conditions. A dedicated biotechnology lab has accelerated the genetic improvement process, evaluating over 1,450 wheat strains to select the best-performing varieties.
“Sharjah’s wheat has exceeded global standards, making it one of the most nutritionally valuable wheat varieties worldwide,” said Dr. Osama Hussein Qambar, an agricultural expert at the Sharjah Department of Agriculture and Livestock.
The farm also integrates other state-of-the art technologies, such as satellite thermal imaging, to optimise yield and quality. A weather monitoring system provides live forecasts, helping to protect crops from environmental fluctuations.
Further pictures can be found here.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250404373415/en/
Contacts
Sabina Nallim
Media Relations Manager
Tel.: +49 30 65000434
s.nallim@mcgroup.com
http://www.mcgroup.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.mcgroup.com
&esheet=54233450&newsitemid=20250404373415&lan=en-US&anchor=http%3A%2F%2Fwww.mcg
roup.com&index=2&md5=31c3db6e48576175a9a17abb53478b3d
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press Release
Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Stable Outlook from Fitch Ratings, assigned on 12 June 2026. Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation of the company’s
Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press Release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magic Quadrant confirms the shift has moved from pilot to boardroom priority. According to Gartner, Visionaries "understands where the market
Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 15:15:00 CEST | Press Release
Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The valve features the company’s FREE next generation tissue treatment addressing the two main causes of calcification, phospholipids and aldehydes. Its proprietary LANCELOT advanced manufacturing process includes zero-pressure shaping and laser cutting of
Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale9.10.2026 15:00:00 CEST | Press Release
Ada, the pioneer in Agentic Customer Experience, today announced it has achieved the Amazon Web Services (AWS) Travel and Hospitality Competency. The designation recognizes Ada as an AWS Partner with demonstrated technical proficiency and proven customer success helping travel and hospitality brands resolve customer issues at scale. Ada joins a select group of 58 AWS Partners holding the competency, and it reflects a shared commitment to helping travel brands deliver service that holds up on their busiest, most unpredictable days. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009673638/en/ Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale "Travel is where agentic customer service gets tested hardest. Demand spikes without warning, policies change by the hour, and customers are often stressed and far from home," said Mike Murchison, CEO and co-founder of Ada. "Our airline and hospitali
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom